ADC Therapeutics SA - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ADCT New York 2836 www.adctherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ADC Therapeutics SA

ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference - Sep 3rd, 2026 5:15 am
ADC Therapeutics (ADCT) Navigates FDA Setback While Cutting Its Losses - Aug 27th, 2026 2:42 pm
ADC Therapeutics (ADCT) Q2 2026 Earnings Call Transcript - Aug 20th, 2026 1:49 pm
ADC Therapeutics (ADCT) Stock Fair Value Falls After LOTIS 5 Reshapes Zynlonta Outlook - Aug 15th, 2026 9:15 pm
ADC Therapeutics S.A. Q2 2026 Earnings Call Summary - Aug 13th, 2026 6:25 pm
ADC Therapeutics SA (ADCT) (Q2 2026) Earnings Call Highlights: Navigating Regulatory Hurdles ... - Aug 13th, 2026 5:07 pm
ADC Therapeutics Q2 Earnings Call Highlights - Aug 13th, 2026 2:04 pm
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates - Aug 13th, 2026 6:50 am
ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates - Aug 13th, 2026 5:30 am
Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates - Aug 6th, 2026 7:50 am
ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026 - Aug 6th, 2026 5:30 am
Alkermes (ALKS) Reports Break-Even Earnings for Q2 - Jul 28th, 2026 6:15 am
The Cancer Therapy Strategy VERAXA Is Betting the Company On - Jul 6th, 2026 10:00 am
ADC Therapeutics Announces New Employee Inducement Grant - Jul 1st, 2026 2:05 pm
ADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination Trial - Jun 30th, 2026 5:15 am
ADC Therapeutics (ADCT) Stock Fair Value Falls After LOTIS 5 Reshapes Analyst Views - Jun 27th, 2026 3:08 am
ADC Therapeutics To Cut About 17% Of Its Staff – A Look At Some Key Details - Jun 24th, 2026 7:13 am
ADC Therapeutics Announces Strategic Reorganization to Support ZYNLONTA® Growth Opportunities and Regulatory Priorities - Jun 24th, 2026 5:30 am
ADC Therapeutics (ADCT) Is Down 69.7% After Mixed LOTIS-5 ZYNLONTA Data - Has The Bull Case Changed? - Jun 7th, 2026 6:17 pm
ADCT Stock Plunges on Safety Concerns Despite Positive Lymphoma Data - Jun 4th, 2026 8:43 am